Acetylcholine and memory-enhancing activity of Ficus racemosa bark

Pharmacognosy Research

Volumn 3, Issue 4, 2011, Pages 246-249

  Ahmed, Faiyaz ^a   Narendra Sharath Chandra, J N ^b   Manjunath, S ^c  

^a Nutra Bio Innovations   (India)

^b Nargund College of Pharmacy and Research Foundation   (India)

^c UNIVERSITY OF MYSORE   (India)

Author keywords

Acetylcholine; Alzheimer disease; memory; plus maze; transfer latency

Indexed keywords

ACETYLCHOLINE; FICUS RACEMOSA AQUEOUS EXTRACT; NOOTROPIC AGENT; PLANT EXTRACT; UNCLASSIFIED DRUG;

ACETYLCHOLINE BRAIN LEVEL; ANIMAL EXPERIMENT; ARTICLE; BARK; COGNITION; CONTROLLED STUDY; DRUG SCREENING; HIPPOCAMPUS; MALE; MEMORY; NONHUMAN;

EID: 84856593882     PISSN: None     EISSN: 09748490     Source Type: Journal    
DOI: 10.4103/0974-8490.89744     Document Type: Article

References (40)

1. Dhingra D, Parle M, Kulkarni SK. Memory enhancing activity of Glycyrrhiza glabra in mice. J Ethnopharmacol 2004;91:361-5.
2. Uriarte PI, Calvo MI. Phytochemical study and evaluation of antioxidant, neuroprotective and acetylcholinesterase inhibitor activities of Galeopsis ladanum L. extracts. Pharmacogn Mag 2009;5:287-90.
3. Nabeshima T. Behavioral aspects of cholinergic transmission: Role of basal forebrain cholinergic system in learning and memory. Prog Brain Res 1993;98:405-11. (Pubitemid 23305673)
4. Ringman JM, Cummings JL. Metrifonate: Update on a new antidementia agent. J Clin Psychiatry 1999;60:776-82.
5. Sramek JJ, Frackiewicz EJ, Cutler NR. Review of acetylcholinesterase inhibitor galanthamine. Expert Opin Investig Drugs 2000;9:2393-402.
6. Mashkovskii MD, Glushkov RG. Drugs for the treatment of Alzheimers disease. Pharm Chem J 2001;35:179-82.
7. Potkin SG, Anand R, Fleming K, Alva G, Keator D, Carreon D, et al. Brain metabolic and clinical effects of rivastigmine in Alzheimers disease. Int J Neuropsychopharmacol 2001;4:223-30. (Pubitemid 34101518)
8. Balaraman R, Shingala J. Nootropic. Indian J Pharmacol 2002;34:439-40.
9. Sugimoto H, Ogura H, Arai Y, Iimura Y, Yamanishi Y. Research and development of donepezil hydrochloride, a new type of anticholinesterase inhibitor. Jpn J Pharmacol 2002;89:7-20. (Pubitemid 34618604)
10. Gauthier S, Emre M, Farlow MR, Bullock R, Grossberg GT, Potkin SG. Strategies for continued successful treatment of Alzheimers disease: Switching cholinesterase inhibitors. Curr Med Res Opin 2003;19:707-14. (Pubitemid 37466140)
11. Bores GM, Huger FP, Petko W, Mutlib AE, Camacho F, Rush DK, et al. Pharmacological evaluation of novel Alzheimers disease therapeutics: Acetylcholinesterase inhibitors related to galanthamine. J Pharmacol Exp Ther 1996;277:728-38. (Pubitemid 27168982)
12. Kartal M, Orhan I, Abu-Asaker M, Senol FS, Atici T, Sener B. Antioxidant and anticholinesterase assets and liquid chromatography-mass spectrometry preface of various fresh-water and marine macroalgae. Pharmacogn Mag 2009;5:291-7.
13. Orhan I, Sener B, Choudhary MI, Khalid A. Acetylcholinesterase and butrylcholinesterase inhibitory activity of some Turkish medicinal plants. J Ethnopharmacol 2004;91:57-60. (Pubitemid 38270227)
14. Ortega MG, Agnese AM, Cabrera JL. Anti-cholinesterase activity in an alkaloid extracts of Huperzia saururus. Phytomedicine 2004;11:539-43. (Pubitemid 39312631)
15. Viegas C, Bolzani VS, Pimentel LS, Castro NG, Cabral RF, Costa RS, et al. New selective acetylcholinesterase inhibitors designed from natural piperidine alkaloids. Bioorg Med Chem 2005;13:4184-90. (Pubitemid 40779387)
16. Roodenrys S, Booth D, Bulzomi S, Phipps A, Micallef C, Smoker J. Chronic effects of Brahmi (Bacopa monnieri) on human memory. Neuropsychopharmacology 2002;27:279-81. (Pubitemid 34686978)
17. Ahmed F, Urooj A. Anticholinesterase activities of cold and hot aqueous extracts of F. racemosa stem bark. Pharmacogn Mag 2010;6:140-2.
18. McGeer EG, McGeer PL. Brain inflammation and the therapeutic implications. Curr Pharm Des 1999;5:821-36.
19. Ebrahimzadeh MA, Ehsanifar S, Eslami B. Sambucus ebulus elburensis fruits: A good source for antioxidants. Pharmacogn Mag 2009;5:213-8.
20. Li RW, Leach DN, Myers SP, Lin GD, Leach GJ, Waterman PG. A new anti-inflammatory glucoside from Ficus racemosa L. Planta Med 2004;70:421-6. (Pubitemid 38716474)
21. Ahmed F, Urooj A. Antioxidant activity of various extracts of Ficus racemosa stem bark. Nat J Life Sci 2009;6:69-74.
22. Sigurdsson EM, Hejna MJ, Lee JM, Lorsen SA. Beta-Amyloid 25-35 and/or quinolinic acid injections into the basal forebrain of young male Fischer-344 rats: Behavioral, neurochemical and histological effects. Behav Brain Res 1995;72:141-56.
23. ONeill JJ, Sakamoto T. Enzymatic fluorometric determination of acetylcholine in biological extracts. J Neurochem 1970;17:1451-60.
24. Parle M, Singh N. Animal models for testing memory. Asia Pac J Pharmacol 2004;16:101-20. (Pubitemid 40125299)
25. Winter SC, Szabo-Aczel S, Curry CJ, Hutchinson HT, Hogue R, Shug A. Plasma carnitine deficiency. Clinical observation in 51 pediatric patients. Am J Dis Child 1987;141:660-5. (Pubitemid 17071247)
26. Sato A, Sato Y, Uchida S. Regulation of cerebral cortical blood flow by basal forebrain cholinergic fibers and aging. Auton Neurosci 2002;96:13-9. (Pubitemid 34158550)
27. Geula C, Mesulam M. Cholinergic systems and related neuropathological predilection patterns in Alzheimer disease. New York: Raven Press; 1994. p. 263-91.
28. Sivaraman D, Muralidaran P. Acetylcholine enhancing activity of methanol leaf extract of Ficus hispida Linn. in rat hippocampus. J Herb Med Toxicol 2009;3:147-50.
29. Vyawahare NS, Bodhankar SL. Effect of Argyreia speciosa extract on learning and memory paradigms in mice. Pharmacogn Mag 2009;5:43-8.
30. Sayre LM, Zagorski MG, Surewicz WK, Krafft GA, Perry G. Mechanisms of neurotoxicity associated with amyloid beta deposition and the role of free radicals in the pathogenesis of Alzheimers disease: A critical appraisal. Chem Res Toxicol 1997;336:1216-22.
31. Ahmed F, Urooj A. Glucose lowering, hepatoprotective and hypolipidemic activity of stem bark of Ficus racemosa in streptozotocin-induced diabetic rats. J Young Pharm 2009;1:160-4.
32. Balas RK, Agha R. Isolation of a hypoglycemic principle from the bark of Ficus glomerata Roxb. Chem Pharm Bull 1985;2:13-4.
33. Joy PP, Thomas J, Mathew S, Skaria BP. Medicinal Plants. Tropical Horticulture. Vol 2. Calcutta: Naya Prokash; 2001. p. 449-632.
34. Khan N, Sultana S. Chemomodulatory effect of Ficus racemosa extract against chemically induced renal carcinogenesis and oxidative damage response in Wistar rats. Life Sci 2005;29:1194-210. (Pubitemid 40898320)
35. Malairajan P, Gopalakrishnan G, Narasimhan S, Veni JK. Analgesic activity of some Indian medicinal plants. J Ethnopharmacol 2006;106:425-8. (Pubitemid 43959839)
36. Nguyen TD, Pham DT, Nguyen TD, Chau VM. Some compounds isolated from Momordica cochinchinensis seed and Ficus glomerata bark. Ly Va Sinh Hoc 2001;6:66-9.
37. Rahman NN, Khan M, Hasan R. Bioactive components from Ficus glomerata. Pure Appl Chem 1994;66:2287-90.
38. Rahuman AA, Venkatesan P, Geetha K, Gopalakrishnan G, Bagavan A, Kamaraj C. Mosquito larvicidal activity of gluanol acetate, a tetracyclic triterpenes derived from Ficus racemosa Linn. Parasitol Res 2008;103:333-9.
39. Singhal RK, Saharia HS. Chemical examination of Ficus glomerata Roxb. Herba Hungarica 1980;19:17-20. (Pubitemid 10013182)
40. Orhan I, Sener B Acetylcholinesterase inhibitors from natural resources. FABAD J Pharm Sci 2003;28:51-8 (Pubitemid 38468661)